Vaccine Delivery Devices Market Size USD 2.3 Bn by 2028 - Credence Research

Some of the major players in the market are Panacea Pharmaceuticals, 3 M, Bioject Medical Technologies, PharmaJet, Valeritas, Vaxxas, Gerresheimer, Schott AG, Corium International, and Becton Dickinson & Company.

Vaccine Delivery Devices Market

The latest market report published by Credence Research, Inc. is?“Global Vaccine Delivery Devices Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028”.?The?Global Vaccine Delivery Devices Market generated revenue of around USD 3.7 billion in 2021 and is anticipated to grow a CAGR of over 8.4% during the forecast period from 2022 to 2028 to reach around USD 6.0 billion in 2028. In contrast, the cumulative growth opportunity presented by the global vaccine delivery devices market is around USD 2.3 billion from 2022 to 2028.

Growing immunization programs and their expanding coverage, increased vaccination research, improved government support and investment, innovation of novel vaccines, and various initiatives and campaigns are key factors driving the market growth. Pharmaceutical and biotech companies collaborate with governments worldwide to develop a strategy for overcoming supply chain issues related to vaccine delivery. The need for a COVID-19 vaccine and the urgency of finding one has sparked interest in developing one or more efficient and secure viral delivery systems. Moreover, technological advancements in vaccine delivery are expected to drive market growth. However, the rising cost of micro-needles, particularly in developing countries, is a major factor impeding market growth.

The global vaccine delivery devices market is bifurcated into Product Type, Route of Administration, End User, and Geography. Based on product type, the market is categorized into syringes, jet injectors, microneedles, aerosol/dry powder inhalation, intranasal delivery devices, and intradermal delivery devices. Based on the route of administration, the global market is segmented into intradermal, intramuscular, subcutaneous, and others. Based on the end user, the market is divided into hospitals, clinics, and others. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

Access?complete report with short-term and long-term impact of COVID-19 on this market.?Please visit:?https://www.credenceresearch.com/report/vaccine-delivery-device-market?

In 2021, North America dominated the global vaccine delivery devices market and accounted for a major market revenue share. The high prevalence of infectious diseases, rising R&D expenditures for new vaccines, and expanding immunization coverage are major regional market expansion drivers. The large regional share of the market is also attributed to sophisticated healthcare infrastructure, high public and professional awareness, and sophisticated healthcare professionals.

Why to Buy This Report –

• The report provides a qualitative and quantitative analysis of the global vaccine delivery devices market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics for the 2016-2020 period, the base year 2021, and the forecast period 2022-2028.
• The report includes competitive landscape information, such as how the market’s key players operate at the global, regional, and country levels.
• In-depth analysis of the market segmentation of the global vaccine delivery devices based on product type, route of administration, and end users.
• The report includes extensive and authentic data for all factors such as supply and demand, CAGR,?consumer purchasing trends, and several?others.
• The global vaccine delivery devices market report includes global, regional, and country-level market analysis, key market trends, major players analysis, market growth strategies, and key application areas.

https://www.credenceresearch.com/